Alto Neuroscience, Inc. - 8-K Filing
Alto Neuroscience appointed Andrew Miller, Ph.D. to its Board of Directors on May 27, 2026, following a recommendation from the Nominating and Corporate Governance Committee. Dr. Miller will serve as an independent Class III director for a term expiring at the 2027 Annual Meeting. He is eligible for stock options under the Non-Employee Director Compensation Policy, including an initial option to purchase up to 48,200 shares of common stock and annual cash retainers totaling $45,000. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $ANRO